Teva begins plant expansion in Hungary
This article was originally published in Scrip
Executive Summary
Teva Pharmaceutical Industriesis to expand its production facility in Debrecen, eastern Hungary, increasing its capacity by 20 billion tablets a year and creating more than 400 new jobs. The project is planned to be completed by 2011. Teva also wants to complete building its R&D centre in Debrecen by the end of next year. The company has invested $630 million in the country since 1995, and its sales in Hungary were Ft175 billion ($1.1 billion) last year.